Board Will Add to Company's Intellectual Capital and Diversity of Experience LAS VEGAS, NV / ACCESSWIRE / October 15, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce William Padilla-Brown as the inaugural candidate for its Scientific and Cultural Advisory Board. A renowned citizen scientist, author, speaker, and mycology thought leader, Padilla-Brown has continually pushed the boundaries of mycological research and public education, making groundbreaking contributions to the cultivation and understanding of fungi.
Company Intends to Bring First Functional Mushroom Producer to Retail LAS VEGAS, NV / ACCESSWIRE / October 7, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, is pleased to announce the addition of significant mycological innovations to its current patent portfolio. The expanded patent portfolio now includes several filings with the United States Patent and Trademark Office (USPTO) that seek to protect a series of novel methods and devices designed to revolutionize the extraction of active components from mycelium and to create high-quality functional mushroom ingredients.
LAS VEGAS, NV / ACCESSWIRE / September 26, 2024 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences, is pleased to announce that the Company has retained Emerging Markets Consulting, LLC (EMC) to provide investor and public relations services. EMC specializes in helping small and mid-sized public companies establish brand awareness and increase market share to its customer base while improving visibility to the institutional and retail investment community.
| Professional Services Industry | Industrials Sector | A. Stone Douglass CEO | OTC PINK Exchange | 253825202 CUSIP |
| US Country | 5 Employees | - Last Dividend | 27 May 2015 Last Split | - IPO Date |
Hypha Labs, Inc. is a pioneering company engaged in the cultivation, production, and sale of psychedelic and functional mushrooms within the United States. With its inception in 2010, the company stands out through its innovative technology, which accelerates the cultivation of mycelium root structures from psilocybin mushrooms as well as other functional mushrooms, converting them into natural products. Based in Las Vegas, Nevada, Hypha Labs not only emphasizes product innovation but also sets a benchmark in the evolving psychedelic and functional mushroom market.
Utilizing their advanced cultivation technology, Hypha Labs produces a range of psilocybin mushroom products. These products are derived from the mycelium of psilocybin mushrooms, focusing on delivering therapeutic benefits. Given the increased interest and ongoing research in the potential mental health benefits of psilocybin, Hypha Labs positions itself as a key player in this innovative health sector.
Alongside psychedelic mushrooms, Hypha Labs also offers products made from the mycelium of various functional mushrooms. These mushrooms, known for their health-boosting properties, are cultivated using the company's proprietary technology. The functional mushroom product line targets consumers interested in natural health supplements, providing alternatives for nutrition, immunity support, and overall wellness.